VRCI vs. PRM, GDR, GENI, DMTR, LLAI, LLA, IDHC, DXRX, AGL, and YGEN
Should you be buying Verici Dx stock or one of its competitors? The main competitors of Verici Dx include Proteome Sciences (PRM), genedrive (GDR), GENinCode (GENI), Deepmatter Group (DMTR), LungLife AI (LLAI), LLA.L,0P0001T9GN,0 (LLA), Integrated Diagnostics (IDHC), Diaceutics (DXRX), ANGLE (AGL), and Yourgene Health (YGEN). These companies are all part of the "diagnostics & research" industry.
Verici Dx vs. Its Competitors
Proteome Sciences (LON:PRM) and Verici Dx (LON:VRCI) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment and valuation.
Proteome Sciences has higher revenue and earnings than Verici Dx. Proteome Sciences is trading at a lower price-to-earnings ratio than Verici Dx, indicating that it is currently the more affordable of the two stocks.
Proteome Sciences has a net margin of -0.04% compared to Verici Dx's net margin of -110.99%. Proteome Sciences' return on equity of -0.01% beat Verici Dx's return on equity.
23.0% of Proteome Sciences shares are owned by institutional investors. Comparatively, 51.9% of Verici Dx shares are owned by institutional investors. 19.5% of Proteome Sciences shares are owned by insiders. Comparatively, 17.1% of Verici Dx shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
In the previous week, Proteome Sciences' average media sentiment score of 0.00 equaled Verici Dx'saverage media sentiment score.
Proteome Sciences has a beta of 0.07, suggesting that its share price is 93% less volatile than the S&P 500. Comparatively, Verici Dx has a beta of 1.59, suggesting that its share price is 59% more volatile than the S&P 500.
Summary
Proteome Sciences beats Verici Dx on 7 of the 11 factors compared between the two stocks.
Get Verici Dx News Delivered to You Automatically
Sign up to receive the latest news and ratings for VRCI and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Verici Dx Competitors List
Related Companies and Tools
This page (LON:VRCI) was last updated on 7/2/2025 by MarketBeat.com Staff
